Last updated: 2026-10-10 15:34:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ClearPoint Neuro, Inc. (CLPT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $10.50, with a market capitalization of $319.99M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.27 to $29.35. This page covers its latest market performance, valuation, price trends and company information.
$319.99M | |
$10.45 | |
$31.29 | |
$2.86 | |
$10.49 | |
376.37K | |
645.99K | |
-- | |
$29.35 | |
$8.27 | |
-- | |
-- |
ClearPoint Neuro, Inc. (CLPT) last closed at $10.49 as of 2026-10-09 23:31:00, unchanged from the previous close of $10.49.
During the latest regular trading session, CLPT traded between $2.86 and $31.29, with a volume of 376.37K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, ClearPoint Neuro, Inc. (CLPT) moved from $11.45 to $10.50, representing a decline of 8.34% ($0.96).
The stock traded between $10.18 and $12.24 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 697.82 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 10.6%
CLPT is currently trading at $10.50, placing it 10.6% of the way from its 52-week low of $8.27 to its 52-week high of $29.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ClearPoint Neuro, Inc. (CLPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.